Isolation and characterization of the promoter region of the rat vasopressin V(1b) receptor gene

Journal of Neuroendocrinology

Volumn 12, Issue 5, 2000, Pages 437-444

  Rabadan Diehl, Cristina ^a   Lolait, S ^b,c   Aguilera, Greti ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Promoter; Transcription start points; V(1b) receptor gene; Vasopressin

Indexed keywords

COMPLEMENTARY DNA; RIBONUCLEASE; VASOPRESSIN V1 RECEPTOR;

ARTICLE; DNA PROBE; DNA SEQUENCE; GENE ISOLATION; HYPOPHYSIS; INTRON; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; RECEPTOR GENE; STRESS; TATA BOX;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BASE SEQUENCE; BINDING SITES; BLOTTING, SOUTHERN; CHO CELLS; COS CELLS; CRICETINAE; DNA, COMPLEMENTARY; LUCIFERASES; MOLECULAR SEQUENCE DATA; PC12 CELLS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RATS; RECEPTORS, VASOPRESSIN; REGULATORY SEQUENCES, NUCLEIC ACID; REPETITIVE SEQUENCES, NUCLEIC ACID; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0034089278     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.2000.00473.x     Document Type: Article

References (35)

1. Antoni FA. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 1993; 14: 76-122.
2. Aguilera G. Regulation of pituitary ACTH secretion during chronic stress. Front Neuroendocrinol 1994; 15: 321-350.
3. deGoeij DCE, Jezova D, Tilders FJH. Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus. Brain Res 1992; 577: 165-168.
4. Peter J, Burbach H, Adan RA, Lolait SJ, van Leeuwen FW, Mezey E, Palkovits M, Barberis C. Molecular neurobiology and pharmacology of the vasopressin/-oxytocin receptor family. Cell Mol Neurobiol 1995; 15: 573-595.
5. 1b vasopressin receptor gene. Proc Natl Acad Sci USA 1995; 92: 6783-6787.
6. 1b vasopressin receptor. J Biol Chem 1994; 266: 27088-27092.
7. Thibonnier M, Graves MK, Wagner MS, Auzan C, Clauser E, Willard HF. Structure, sequence, expression, and chromosomal localization of the human V1a vasopressin receptor gene. Genomics 1996; 31: 327-334.
8. Seibold A, Grabet P, Rosenthal W, Birnbaumer M. Structure and chromosomal localization of the human antidiuretic hormone receptor gene. Am J Hum Genet 1992; 51: 1078-1083.
9. Aguilera G, Pham Q, Rabadan-Diehl C. Regulation of pituitary vasopressin receptors during chronic stress: relationship to corticotroph reponsiveness. J Neuroendocrinol 1994; 6: 299-304.
10. 1b, receptor mRNA during stress in the rat. J Neuroendocrinol 1995; 7: 903-910.
11. 1b vasopressin receptor: evidence for its expression in extra-pituitary tissues. Biochem Biophys Res Commun 1995; 212: 751-757.
12. 1b pituitary vasopressin receptor. J Mol Endocrinol 1999; 22: 251-260.
13. 1a vasopressin receptor gene and characterization of its promoter region and complete cDNA sequence of the 3′-end. J Biol Chem 1995; 270: 20042-20050.
14. Rozen F, Russo C, Banville D, Zingg HH. Structure, characterization, and expression of the rat oxytocin receptor gene. Proc Natl Acad Sci USA 1995; 92: 200-204.
15. Inoue T, Kimura T, Azuma C, Inazawa J, Takemura M, Kikuchi T, Kubota Y, Ogita K, Saji F. Structural organization of the human oxytocin receptor gene. J Biol Chem 1994; 269: 32451-32456.
16. Mount SM. A catalogue of splice junction sequences. Nucl Acids Res 1982; 10: 459.
17. Brooks AR, Blackhart BD, Haubold Levy-Wilson B. Characterization of tissue-specific enhancer elements the second intron of the human apolipoprotein B gene. J Biol Chem 1991; 266: 7848-7859.
18. Hambor JE, Mennone J, Coon ME, Hanke JH, Kavathas P. Identification and characterization of an Alu-containing, T-cell-specific enhancer located in the last intron of the human CD8 alpha gene. Mol Cell Biol 1993; 13: 7056-7070.
19. Voigtländer T, Ganten D, Bader M. Transcriptional regulation of the rat renin gene by regulatory elements in intron I. Hypertension 1999; 33: 303-311.
20. Mizumoto Y, Kimura T, Ivell R. A genomic element within the third intron of the human oxytocin receptor gene may be involved in transcriptional suppression. Mol Cell Endocrinology 1997; 135: 129-138.
21. Carter DA. Transgenic rodents and the study of the central nervous system. In: Murphy D. Carter DA, eds. Methods in Molecular Biology, Vol 18: Transgenesis Techniques: Principles and Protocols. Totowa, NJ: Humana Press, 1993: 7-22.
22. Woods MD, Shipston MJ, Mullens EL, Antoni KA. Pituitary corticotrope tumor (AtT20) cells as a model system for the study of early inhibition by glucocorticoids. Endocrinology 1992; 131: 2873-2880.
23. Iredale PA, Duman RS. Glucocorticoid regulation of corticotropin-releasing factor1 receptor expression in pituitary derived AtT20 cells Mol Pharmacol 1997; 51: 794-799.
24. Rabadan-Diehl C, Makara G, Kiss A, Lolait S, Zelena D, Ochedalski T, Aguilera G. Regulation of pituitary V1b receptor messenger ribonucleic acid by adrenalectomy and glucocorticoid administration. Endocrinology 1997; 138: 5189-5194.
25. Carvallo P, Aguilera G. Protein Kinase C mediates the effect of vasopressin in pituitary corticotrophs. Mol Endocrinol 1989; 3: 1935-1943.
26. Roesler WJ, Park EA, McFie PJ. Characterization of CCAAT/enhancer-binding protein (as a cyclic AMP-responsive nuclear regulator. J Biol Chem 1998; 273: 14950-14957.
27. Grønning LM, Dahle MK, Taskén KA, Enerbäck S, Hedin L, Taskén K. Knutsen HK. Isoform-specific regulation of the CCAAT enhancer-binding protein family of transcription factors by 3′,5′ adenosine monophosphate in sertoli cells. Endocrinology 1999; 140: 835-843.
28. Imagawa M, Chiu R, Karin M. Transcription Factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and camp. Cell 1987; 51: 251-260.
29. Chen S, Shi H, Liu X, Segaloff DL. Multiple elements and protein factors coordinate the basal and cyclic adenosine 3′,5′-Monophosphate-Induced transcription of the Lutropin Receptor Gene in Rat Granulosa Cells. Endocrinology 1999; 140: 2100-2109.
30. Katsani KR, Hajibagheri MA, Verrijzer CP. Co-operative DNA binding by GAGA transcription factor requires the conserved BTB/POZ domain and reorganizes promoter topology. EMBO J 1999; 18: 698-708.
31. Simar-Blanchet AE, Legraverand C, Thissen JP, Cam A. Transcription of the rat serine protease inhibitor 2.1 gene in vivo: correlation with GAGA box promoter occupancy and mechanism of cytokine-mediated down-regulation. Mol Endocrinol 1998; 12: 391-404.
32. Legraverand C, Simar-Blanchet AE, Paul C, Sotiropoulos A, Finidori J, Cam AL. A novel growth hormone response element unrelated to STAT (signal transducer and activator of transcription)-binding sites is a bifunctional enhancer. Mol Endocrinol 1996; 10: 1507-1518.
33. Lyubchenko YL, Shyakhtenko LS, Appella E, Harrington RE. CA runs increase DNA flexibility in the complex of lambda Cro protein with the OR3 site. Biochemistry 1993; 32: 4121-4127.
34. Anagnou NP, Moulton AD, Keller G, Karlsson S, Papayannopoulou T, Stamatoyannopoulos G, Nienhuis AW. Cis-acting sequences that affect the expression of the human fetal gamma-globin genes. Prog Clin Biol Res 1985; 191: 163-182.
35. Bale T, Dorsa D. Cloning, novel promoter sequence, and estrogen regulation of a rat oxytocin receptor gene. Endocrinology 1997; 138: 1151-1158.